CIK 1920938
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 57.81% | 49 |
| Health Care Equipment & Supplies | 14.56% | 11 |
| Health Care Providers & Services | 12.81% | 9 |
| Unclassified | 5.22% | 4 |
| Technology Hardware & Equipment | 2.75% | 2 |
| Software & IT Services | 2.14% | 1 |
| Professional Services | 1.59% | 1 |
| Life Sciences Tools & Services | 1.24% | 2 |
| Insurance | 1.10% | 2 |
| Food & Staples Retailing | 0.80% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | CAI | Caris Life Sciences, Inc. | Health Care | 5.45% |
| 2 | NBIX | NEUROCRINE BIOSCIENCES INC | Health Care | 3.27% |
| 3 | GKOS | GLAUKOS Corp | Health Care | 3.13% |
| 4 | CENTESSA PHARMACEUTICALS PLC | Unclassified | 3.01% | |
| 5 | XENE | Xenon Pharmaceuticals Inc. | Health Care | 2.96% |
| 6 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Health Care | 2.87% |
| 7 | EWTX | Edgewise Therapeutics, Inc. | Health Care | 2.82% |
| 8 | IRTC | iRhythm Holdings, Inc. | Health Care | 2.74% |
| 9 | NUVL | Nuvalent, Inc. | Health Care | 2.73% |
| 10 | KOD | Kodiak Sciences Inc. | Health Care | 2.64% |
78/82 names classified · sector 94.8% of weight · industry 94.8% · mkt cap 90.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 94.8% of the book is sector-classified (unclassified names shown, never dropped).
Only 21% of book weight classified — the grid is NOT representative of the whole book.
Classified: 21.3% of book weight (19/80 names) · unclassified 78.7%: CAI, , GKOS, XENE, DNTH, EWTX, IRTC, NUVL, KOD, CGON +51 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CAICARIS LIFE SCIENCES INC | 8,009,447 | $143M | 5.5% | ADD 2% |
| 2 | NBIXNEUROCRINE BIOSCIENCES INC | 652,121 | $86M | 3.3% | TRIM −13% |
| 3 | GKOSGLAUKOS CORP | 763,505 | $82M | 3.1% | TRIM −17% |
| 4 | CENTESSA PHARMACEUTICALS PLC | 1,986,768 | $79M | 3.0% | TRIM −9% |
| 5 | XENEXENON PHARMACEUTICALS INC | 1,338,452 | $78M | 3.0% | TRIM −27% |
| 6 | DNTHDIANTHUS THERAPEUTICS INC | 899,364 | $75M | 2.9% | TRIM −29% |
| 7 | EWTXEDGEWISE THERAPEUTICS INC | 2,347,583 | $74M | 2.8% | TRIM −55% |
| 8 | IRTCIRHYTHM HOLDINGS INC | 610,192 | $72M | 2.7% | ADD 181% |
| 9 | NUVLNUVALENT INC | 700,429 | $72M | 2.7% | TRIM −15% |
| 10 | KODKODIAK SCIENCES INC | 1,818,665 | $69M | 2.6% | TRIM −12% |
| 11 | CGONCG ONCOLOGY INC | 984,783 | $67M | 2.5% | TRIM −47% |
| 12 | ARGXARGENX SE | 84,939 | $62M | 2.4% | ADD 174% |
| 13 | HNGEHINGE HEALTH INC | 1,455,123 | $56M | 2.1% | ADD 12% |
| 14 | ACADACADIA PHARM | 2,471,199 | $55M | 2.1% | ADD 22% |
| 15 | GLUEMONTE ROSA THERAPEUTICS INC | 3,206,574 | $53M | 2.0% | ADD 238% |
| 16 | KRYSKRYSTAL BIOTECH INC | 182,425 | $47M | 1.8% | TRIM −10% |
| 17 | SYRESPYRE THERAPEUTICS INC | 932,823 | $47M | 1.8% | TRIM −43% |
| 18 | GHGUARDANT HEALTH INC | 499,712 | $46M | 1.8% | NEW |
| 19 | TMOTHERMO FISHER SCIENTIFIC INC | 92,915 | $46M | 1.7% | ADD 15% |
| 20 | GENBGENERATE BIOMEDICINES INC | 3,592,999 | $45M | 1.7% | NEW |
| 21 | MBXMBX BIOSCIENCES INC | 1,492,467 | $45M | 1.7% | ADD 47% |
| 22 | BTSGBRIGHTSPRING HEALTH SVCS INC | 1,016,562 | $43M | 1.6% | TRIM −15% |
| 23 | CLDXCELLDEX THERAPEUTICS INC NEW | 1,356,082 | $43M | 1.6% | TRIM −27% |
| 24 | NEONEOGENOMICS INC | 5,617,402 | $42M | 1.6% | ADD 21% |
| 25 | APGEAPOGEE THERAPEUTICS INC | 478,667 | $40M | 1.5% | TRIM −17% |
| 26 | DRUGBRIGHT MINDS BIOSCIENCES INC | 539,708 | $39M | 1.5% | ADD 66% |
| 27 | CDNACAREDX INC | 2,173,146 | $38M | 1.4% | ADD 37% |
| 28 | ISRGINTUITIVE SURGICAL INC | 77,297 | $36M | 1.4% | TRIM −7% |
| 29 | INSPINSPIRE MED SYS INC | 677,570 | $35M | 1.3% | ADD 25% |
| 30 | PENPENUMBRA INC | 105,352 | $35M | 1.3% | TRIM −4% |
| 31 | TMDXTRANSMEDICS GROUP INC | 329,391 | $33M | 1.2% | ADD 4% |
| 32 | SOLENO THERAPEUTICS INC | 959,259 | $32M | 1.2% | TRIM −19% |
| 33 | DYNDYNE THERAPEUTICS INC | 1,681,998 | $30M | 1.2% | ADD 14% |
| 34 | MRVIMARAVAI LIFESCIENCES HLDGS I | 10,240,164 | $29M | 1.1% | ADD 23% |
| 35 | ILMNILLUMINA INC | 229,215 | $28M | 1.1% | TRIM −15% |
| 36 | KYMRKYMERA THERAPEUTICS INC | 337,559 | $28M | 1.1% | TRIM −26% |
| 37 | BMRNBIOMARIN PHARMACEUTICAL INC | 497,020 | $28M | 1.1% | TRIM −17% |
| 38 | NRIXNURIX THERAPEUTICS INC | 1,750,766 | $27M | 1.0% | TRIM −20% |
| 39 | RYTMRHYTHM PHARMACEUTICALS INC | 310,628 | $27M | 1.0% | NEW |
| 40 | DHRDANAHER CORP DEL | 139,327 | $26M | 1.0% | ADD 18% |
| 41 | ESTAESTABLISHMENT LABS HLDGS INC | 463,600 | $26M | 1.0% | NEW |
| 42 | TECXTECTONIC THERAPEUTIC INC | 847,151 | $26M | 1.0% | TRIM −9% |
| 43 | NTRANATERA INC | 129,000 | $26M | 1.0% | ADD 16% |
| 44 | CRVSCORVUS PHARMACEUTICALS INC | 1,752,798 | $26M | 1.0% | NEW |
| 45 | FULCFULCRUM THERAPEUTICS INC | 3,134,922 | $24M | 0.9% | ADD 2% |
| 46 | ZURAZURA BIO LTD | 3,988,989 | $24M | 0.9% | ADD 25% |
| 47 | ATECALPHATEC HLDGS INC | 2,172,725 | $24M | 0.9% | NEW |
| 48 | DMRADAMORA THERAPEUTICS INC | 894,846 | $23M | 0.9% | NEW |
| 49 | BSXBOSTON SCIENTIFIC CORP | 346,467 | $22M | 0.8% | NEW |
| 50 | VERAVERA THERAPEUTICS INC | 523,824 | $21M | 0.8% | TRIM −33% |
| 51 | BIOABIOAGE LABS INC | 1,200,587 | $21M | 0.8% | NEW |
| 52 | CVSCVS HEALTH CORP | 290,700 | $21M | 0.8% | TRIM −48% |
| 53 | TARSTARSUS PHARMACEUTICALS INC | 265,715 | $19M | 0.7% | NEW |
| 54 | ELVELEVANCE HEALTH INC FORMERLY | 62,080 | $18M | 0.7% | NEW |
| 55 | KIDSORTHOPEDIATRICS CORP | 1,100,370 | $17M | 0.7% | HOLD |
| 56 | ENGENE HOLDINGS INC | 2,456,870 | $17M | 0.6% | TRIM −22% |
| 57 | NKTRNEKTAR THERAPEUTICS | 222,701 | $16M | 0.6% | NEW |
| 58 | ACHCACADIA HEALTHCARE COMPANY IN | 645,900 | $15M | 0.6% | NEW |
| 59 | ORICORIC PHARMACEUTICALS INC | 1,128,040 | $14M | 0.5% | NEW |
| 60 | AVAHAVEANNA HEALTHCARE HLDGS INC | 2,203,506 | $14M | 0.5% | NEW |
| 61 | XFORX4 PHARMACEUTICALS INC | 3,272,954 | $14M | 0.5% | TRIM −3% |
| 62 | KNSAKINIKSA PHARMACEUTICALS INTL | 272,522 | $13M | 0.5% | TRIM −13% |
| 63 | EOLSEVOLUS INC | 3,105,209 | $13M | 0.5% | HOLD |
| 64 | TGTXTG THERAPEUTICS INC | 358,800 | $12M | 0.5% | NEW |
| 65 | SRZNSURROZEN INC | 396,100 | $12M | 0.4% | TRIM −16% |
| 66 | CNCCENTENE CORP DEL | 330,000 | $11M | 0.4% | NEW |
| 67 | CLYMCLIMB BIO INC | 1,529,675 | $10M | 0.4% | NEW |
| 68 | CMPXCOMPASS THERAPEUTICS INC | 1,965,106 | $10M | 0.4% | TRIM −29% |
| 69 | IONSIONIS PHARMACEUTICALS INC | 130,862 | $10M | 0.4% | NEW |
| 70 | HLXCHELIX ACQUISITION CORP III | 900,000 | $9M | 0.4% | NEW |
| 71 | VORVOR BIOPHARMA INC | 466,774 | $8M | 0.3% | NEW |
| 72 | RVMDREVOLUTION MEDICINES INC | 84,900 | $8M | 0.3% | NEW |
| 73 | GRALGRAIL INC | 142,755 | $7M | 0.3% | HOLD |
| 74 | ACRSACLARIS THERAPEUTICS INC | 1,699,116 | $6M | 0.2% | NEW |
| 75 | DNLIDENALI THERAPEUTICS INC | 296,324 | $6M | 0.2% | NEW |
| 76 | RGENREPLIGEN CORP | 47,500 | $6M | 0.2% | TRIM −42% |
| 77 | HROWHARROW INC | 156,419 | $6M | 0.2% | TRIM −47% |
| 78 | RVTYREVVITY INC | 48,400 | $4M | 0.2% | NEW |
| 79 | CELCCELCUITY INC | 29,198 | $3M | 0.1% | NEW |
| 80 | PRAXPRAXIS PRECISION MEDICINES I | 9,976 | $3M | 0.1% | NEW |
| 81 | LUNGPULMONX CORP | 752,541 | $970,778 | 0.0% | HOLD |
| 82 | VYNEVYNE THERAPEUTICS INC | 916,077 | $547,356 | 0.0% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| CAICARIS LIFE SCIENCES INC | — | — | 7.3M | 7.3M | 7.8M | 8.0M | $143M |
| NBIXNEUROCRINE BIOSCIENCES INC | 902K | 1.2M | 1.2M | 880K | 752K | 652K | $86M |
| GKOSGLAUKOS CORP | 289K | 624K | 603K | 780K | 922K | 764K | $82M |
| CENTESSA PHARMACEUTICALS PLC | — | — | — | — | 2.2M | 2.0M | $79M |
| XENEXENON PHARMACEUTICALS INC | 2.9M | 2.7M | 3.6M | 3.6M | 1.8M | 1.3M | $78M |
| DNTHDIANTHUS THERAPEUTICS INC | 1.2M | 375K | — | 835K | 1.3M | 899K | $75M |
| EWTXEDGEWISE THERAPEUTICS INC | 2.3M | 2.5M | 5.2M | 5.2M | 5.2M | 2.3M | $74M |
| IRTCIRHYTHM HOLDINGS INC | 705K | 556K | 300K | 226K | 217K | 610K | $72M |
| NUVLNUVALENT INC | 241K | 841K | 1.2M | 1.0M | 821K | 700K | $72M |
| KODKODIAK SCIENCES INC | — | — | — | — | 2.1M | 1.8M | $69M |
| CGONCG ONCOLOGY INC | 3.3M | 3.3M | 3.3M | 3.3M | 1.9M | 985K | $67M |
| ARGXARGENX SE | 81K | 161K | 194K | 76K | 31K | 85K | $62M |
| HNGEHINGE HEALTH INC | — | — | — | 910K | 1.3M | 1.5M | $56M |
| ACADACADIA PHARM | — | — | — | 2.4M | 2.0M | 2.5M | $55M |
| GLUEMONTE ROSA THERAPEUTICS INC | — | — | — | — | 948K | 3.2M | $53M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
